Real-World Experience of Chronic Hepatitis C-Related Compensated Liver Cirrhosis Treated with Glecaprevir/Pibrentasvir: A Multicenter Retrospective Study.
Pei-Yuan SuYang-Yuan ChenJun-Hung LaiHung-Ming ChenChih-Ta YaoI-Ling LiuYa-Huei ZengSiou-Ping HuangYu-Chun HsuShun-Sheng WuFu-Yuan SiaoHsu-Heng YenPublished in: Journal of clinical medicine (2021)
the glecaprevir/pibrentasvir treatment regimen was highly effective and well tolerated among patients with compensated cirrhosis in the real-world setting.